Microsporidial infections in humans: current practice and developments in laboratory diagnosis.

Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Microsporidial infections in humans: current practice and developments in laboratory diagnosis.

Br J Biomed Sci. 1997 Sep;54(3):216-21. Unique Identifier : AIDSLINE MED/98160574
Windsor JJ; Department of Microbiology and Immunology, College of Medicine, Sultan; Qaboos University, Muscat, Sultanate of Oman.

Abstract: Microsporidia are small, intracellular parasites that infect a wide range of hosts, including vertebrates, invertebrates and fish. They were discovered more than a century ago. The first well documented human case, however, was not reported until 100 years later. Since the first case of intestinal microsporidiosis was reported in 1985, numerous cases of microsporidiosis have been reported in immunocompromised patients, especially those in the later stages of human immunodeficiency virus (HIV) infection. Microsporidia also have been described in various other clinical conditions, including keratoconjunctivitis, sinusitis, peritonitis and myositis. The numbers of cases reported have risen dramatically since 1985, which can be explained partly by the acquired immune deficiency syndrome (AIDS) pandemic and partly by increased laboratory awareness. Some studies have shown that up to 50% of selected AIDS patients are infected with microsporidia. Diagnosis depended initially on the use of invasive techniques, namely histological examination of biopsy material. Since then, however, there have been important advances in the detection of microsporidial spores in clinical samples. Recent developments in the diagnosis of microsporidiosis are described, including light microscopy staining methods, fluorescent staining, electron microscopy and molecular techniques.

Keywords: *Microspora Infections/DIAGNOSIS *Microsporida/CLASSIFICATION
980630
M9861824

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .